Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Vertice Pharma Management Corp
EIR
•Vertice Pharma Management Corp•August 29, 2018

Vertice Pharma Management Corp – FDA EIR, Aug 29, 2018

Record Details

Vertice Pharma Management Corp. underwent its first FDA Pre-Approval inspection from August 27-29, 2018, as a contract testing laboratory in Bridgewater, NJ. The inspection, conducted under Compliance Programs 52832 and 56002, focused on the firm's readiness for commercial manufacturing, conformance to application for an ANDA held by VistaPharm, and data integrity. While no FDA Form 483 was issued, three verbal observations were discussed with management, who agreed to initiate corrective actions.

Key issues identified included the absence of a written procedure defining the Quality Unit's roles and responsibilities, insufficient detail captured in change control documentation, and the use of non-validated, uncontrolled spreadsheets for critical GMP calculations (assay and impurity). These spreadsheets were not password-protected and were accessible to all analysts, raising data integrity concerns. Other observations noted were incomplete laboratory logbooks for sample receipt status and pH meter usage, a purified water conductivity out-of-specification result, and a dissolution procedure lacking a specific pre-testing step.

Management committed to addressing these observations, including updating change control processes for better detail, ensuring no GMP testing occurs in the R&D area, revising logbook procedures, enhancing shipping condition controls, updating the water quality SOP, and either validating existing calculation spreadsheets or integrating calculations into chromatographic software.

Company
Vertice Pharma Management Corp
Inspection date
August 29, 2018
Product type
drugs
Office
New Jersey District Office
Person
  • Lata C. Mathew
View Company Profile

ID · a11d7837-6baf-4948-8838-84166249b0de

Violation Codes1
21 CFR 820.198

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Vertice Pharma Management Corp
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.